Drug Information

Drug General Information
Drug ID
D0Y6MH
Former ID
DCL001015
Drug Name
Tebipenem
Synonyms
Tebipenem [INN]
Drug Type
Small molecular drug
Indication Nicotine dependence; Obesity [ICD9: 278, 305.1; ICD10:E66, F17] Phase 2 [536122]
Company
Sanofi-Aventis
Formula
C16H21N3O4S2
Canonical SMILES
CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)C(C)O
InChI
1S/C16H21N3O4S2/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)25-9-5-18(6-9)16-17-3-4-24-16/h7-11,20H,3-6H2,1-2H3,(H,22,23)/t7-,8-,10-,11-/m1/s1
InChIKey
GXXLUDOKHXEFBQ-YJFSRANCSA-N
CAS Number
CAS 158681-13-1
PubChem Compound ID
9800194
PubChem Substance ID
14756066, 14804801, 24109293, 44836199, 80039199, 103699045, 162108852, 198961420, 239741870, 249049042, 252448243
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Antagonist [536122]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 536122Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.
Ref 536122Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.